Medicine
Adasuve 10 mg inhalation powder
Adasuve 10 mg inhalation powder is a prescription medicine containing Loxapine for inhalation use, marketed by Alexza Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store ADASUVE at room temperature, 15° to 30°C (59° to 86°F).
Key facts
- Active ingredient (INN)
- Loxapine
- Brand
- Adasuve
- Strength
- 10 mg
- Dosage form
- Inhalation powder
- Route
- Inhalation
- Packs
- 5 inhalers
- Marketing authorisation holder
- Alexza Pharmaceuticals
- Manufacturer
- Alexza Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store ADASUVE at room temperature, 15° to 30°C (59° to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N05AH01 Loxapine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 6 July 2026
- Identifiers
- RxCUI 1367518, 1367521DailyMed set ID 50e11732-7387-452d-b3e6-db3a431d5c4aNDC 51097-001Application NDA022549
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 5 inhaler in 1 carton / 1 aerosol, powder in 1 inhaler | 51097-001-02 | Alexza Pharmaceuticals | 6 July 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Loxapine
Clinical summary
Loxapine is a prescription medicine indicated for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults. It is available as capsules and inhalation powder for oral use. MedsAcross supplies Loxapine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about LoxapineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Adasuve prescribing information (Alexza Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Adasuve: European public assessment report (EPAR) · European Medicines Agency
Need Adasuve 10 mg inhalation powder for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.